Clinical Trial Update: Avastin and Taxotere for Esophagogastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating Avastin and Taxotere for esophagogastric cancers has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Taxotere (docetaxel)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Esophageal Cancer, Gastric Cancer | Phase 2 | Status: COMPLETED